| 000 | 01526 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515175038.0 | ||
| 264 | 0 | _c20110824 | |
| 008 | 201108s 0 0 chi d | ||
| 022 | _a1009-2137 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhu, Bo-Gui | |
| 245 | 0 | 0 |
_a[Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming in 50 patients with relapsed acute myeloid leukemia]. _h[electronic resource] |
| 260 |
_bZhongguo shi yan xue ye xue za zhi _cJun 2009 |
||
| 300 |
_a760-4 p. _bdigital |
||
| 500 | _aPublication Type: Controlled Clinical Trial; English Abstract; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAclarubicin _xadministration & dosage |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aQian, Si-Xuan | |
| 700 | 1 | _aHong, Ming | |
| 700 | 1 | _aLu, Hua | |
| 700 | 1 | _aWu, Han-Xin | |
| 700 | 1 | _aZhang, Su-Jiang | |
| 700 | 1 | _aQiu, Hong-Xia | |
| 700 | 1 | _aXu, Wei | |
| 700 | 1 | _aLi, Jian-Yong | |
| 773 | 0 |
_tZhongguo shi yan xue ye xue za zhi _gvol. 17 _gno. 3 _gp. 760-4 |
|
| 999 |
_c18967124 _d18967124 |
||